SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium